Arresting serotonin

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 3, 2008, Pages 831-832

  Abbas, Atheir ^a   Roth, Bryan L ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 HYDROXYTRYPTOPHAN; ARACHIDONIC ACID; ARIPIPRAZOLE; BETA ARRESTIN 2; BIFEPRUNOX; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; LISURIDE; LYSERGIDE; PHOSPHOLIPASE C; PRECLAMOL; RETINA S ANTIGEN; SEROTONIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN AGONIST; BETA ARRESTIN;

CENTRAL NERVOUS SYSTEM; DRUG MECHANISM; FIBROBLAST; HUMAN; NERVE CELL; NONHUMAN; NOTE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; METABOLISM;

ANIMALS; ARRESTINS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 38949184303     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0711335105     Document Type: Note

References (18)

1. Schmid CL, Raehal KM, Bohn LM (2008) Proc Natl Acad Sci USA 105:1079-1084.
2. Furchgott RF (1966) in Advances in Drug Research, eds Harper N, Simmonds A (Academic, New York), Vol 3, pp 21-55.
3. Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, et al. (2007) J Pharmacol Exp Ther 320:1-13.
4. Nichols DE (2004) Pharmacol Ther 101:131-181.
5. Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, et al. (2007) Neuron 53:439-452.
6. Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP (1998) Mol Pharmacol 54:94-104.
7. Kurrasch-Orbaugh DM, Watts VJ, Barker EL, Nichols DE (2003) J Pharmacol Exp Ther 304:229-237.
8. Kenakin T (2002) Nat Rev Drug Discov 1:103-110.
9. Violin JD, Lefkowitz RJ (2007) Trends Pharmacol Sci 28:416-422.
10. Yan F, Mosier PD, Westkaemper RB, Roth BL (2008) Biochemistry, in press.
11. Glennon RA, Titler M, McKenney JD (1984) Life Sci 35:2505-2511.
12. Gray JA, Sheffler DJ, Bhatnagar A, Woods JA, Hufeisen SJ, Benovic JL, Roth BL (2001) Mol Pharmacol 60:1020-1030.
13. Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, Shenoy SK, Lefkowitz RJ (2007) Proc Natl Acad Sci USA 104:16657-16662.
14. Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R (2003) Neuropsychopharmacology 28:1400-1411.
15. Urban JD, Vargas GA, von Zastrow M, Mailman RB (2007) Neuropsychopharmacology 32:67-77.
16. Mailman RB (2007) Trends Pharmacol Sci 28:390-396.
17. Lefkowitz RJ, Rajagopal K, Whalen J (2006) Mol Cell 24:643-652.
18. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Annu Rev Physiol 69:483-510.